Global Drugs for Short Bowel Syndrome Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Jan-2021
No. of pages: 96
Inquire Before Buying

Drugs for Short Bowel Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Short Bowel Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- GLP-2

- Growth Hormone

- Glutamine

- Other

Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Ardelyx

- Emmaus Life Sciences

- GLyPharma Therapeutic

- Merck

- Naia Pharmaceuticals

- Nutrinia

- OxThera

- Sancilio & Company

- Takeda

- Merck

Global Drugs for Short Bowel Syndrome Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 GLP-2
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Market by Application
1.3.1 Global Drugs for Short Bowel Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Short Bowel Syndrome Market Perspective (2016-2027)
2.2 Drugs for Short Bowel Syndrome Growth Trends by Regions
2.2.1 Drugs for Short Bowel Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drugs for Short Bowel Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Drugs for Short Bowel Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Drugs for Short Bowel Syndrome Industry Dynamic
2.3.1 Drugs for Short Bowel Syndrome Market Trends
2.3.2 Drugs for Short Bowel Syndrome Market Drivers
2.3.3 Drugs for Short Bowel Syndrome Market Challenges
2.3.4 Drugs for Short Bowel Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue
3.1.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue (2016-2021)
3.1.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Drugs for Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drugs for Short Bowel Syndrome Revenue
3.4 Global Drugs for Short Bowel Syndrome Market Concentration Ratio
3.4.1 Global Drugs for Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Short Bowel Syndrome Revenue in 2020
3.5 Drugs for Short Bowel Syndrome Key Players Head office and Area Served
3.6 Key Players Drugs for Short Bowel Syndrome Product Solution and Service
3.7 Date of Enter into Drugs for Short Bowel Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Short Bowel Syndrome Breakdown Data by Type
4.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2022-2027)
5 Drugs for Short Bowel Syndrome Breakdown Data by Application
5.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Drugs for Short Bowel Syndrome Market Size (2016-2027)
6.2 North America Drugs for Short Bowel Syndrome Market Size by Type
6.2.1 North America Drugs for Short Bowel Syndrome Market Size by Type (2016-2021)
6.2.2 North America Drugs for Short Bowel Syndrome Market Size by Type (2022-2027)
6.2.3 North America Drugs for Short Bowel Syndrome Market Size by Type (2016-2027)
6.3 North America Drugs for Short Bowel Syndrome Market Size by Application
6.3.1 North America Drugs for Short Bowel Syndrome Market Size by Application (2016-2021)
6.3.2 North America Drugs for Short Bowel Syndrome Market Size by Application (2022-2027)
6.3.3 North America Drugs for Short Bowel Syndrome Market Size by Application (2016-2027)
6.4 North America Drugs for Short Bowel Syndrome Market Size by Country
6.4.1 North America Drugs for Short Bowel Syndrome Market Size by Country (2016-2021)
6.4.2 North America Drugs for Short Bowel Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Drugs for Short Bowel Syndrome Market Size (2016-2027)
7.2 Europe Drugs for Short Bowel Syndrome Market Size by Type
7.2.1 Europe Drugs for Short Bowel Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Drugs for Short Bowel Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Drugs for Short Bowel Syndrome Market Size by Type (2016-2027)
7.3 Europe Drugs for Short Bowel Syndrome Market Size by Application
7.3.1 Europe Drugs for Short Bowel Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Drugs for Short Bowel Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Drugs for Short Bowel Syndrome Market Size by Application (2016-2027)
7.4 Europe Drugs for Short Bowel Syndrome Market Size by Country
7.4.1 Europe Drugs for Short Bowel Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Drugs for Short Bowel Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type
8.2.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application
8.3.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region
8.4.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drugs for Short Bowel Syndrome Market Size (2016-2027)
9.2 Latin America Drugs for Short Bowel Syndrome Market Size by Type
9.2.1 Latin America Drugs for Short Bowel Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Drugs for Short Bowel Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Drugs for Short Bowel Syndrome Market Size by Type (2016-2027)
9.3 Latin America Drugs for Short Bowel Syndrome Market Size by Application
9.3.1 Latin America Drugs for Short Bowel Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Drugs for Short Bowel Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Drugs for Short Bowel Syndrome Market Size by Application (2016-2027)
9.4 Latin America Drugs for Short Bowel Syndrome Market Size by Country
9.4.1 Latin America Drugs for Short Bowel Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Drugs for Short Bowel Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type
10.2.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application
10.3.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country
10.4.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ardelyx
11.1.1 Ardelyx Company Details
11.1.2 Ardelyx Business Overview
11.1.3 Ardelyx Drugs for Short Bowel Syndrome Introduction
11.1.4 Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.1.5 Ardelyx Recent Development
11.2 Emmaus Life Sciences
11.2.1 Emmaus Life Sciences Company Details
11.2.2 Emmaus Life Sciences Business Overview
11.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Introduction
11.2.4 Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.2.5 Emmaus Life Sciences Recent Development
11.3 GLyPharma Therapeutic
11.3.1 GLyPharma Therapeutic Company Details
11.3.2 GLyPharma Therapeutic Business Overview
11.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Introduction
11.3.4 GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.3.5 GLyPharma Therapeutic Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Drugs for Short Bowel Syndrome Introduction
11.4.4 Merck Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Details
11.5.2 Naia Pharmaceuticals Business Overview
11.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Introduction
11.5.4 Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.5.5 Naia Pharmaceuticals Recent Development
11.6 Nutrinia
11.6.1 Nutrinia Company Details
11.6.2 Nutrinia Business Overview
11.6.3 Nutrinia Drugs for Short Bowel Syndrome Introduction
11.6.4 Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.6.5 Nutrinia Recent Development
11.7 OxThera
11.7.1 OxThera Company Details
11.7.2 OxThera Business Overview
11.7.3 OxThera Drugs for Short Bowel Syndrome Introduction
11.7.4 OxThera Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.7.5 OxThera Recent Development
11.8 Sancilio & Company
11.8.1 Sancilio & Company Company Details
11.8.2 Sancilio & Company Business Overview
11.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Introduction
11.8.4 Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.8.5 Sancilio & Company Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Drugs for Short Bowel Syndrome Introduction
11.9.4 Takeda Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.9.5 Takeda Recent Development
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Details
11.10.2 Zealand Pharma Business Overview
11.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Introduction
11.10.4 Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.10.5 Zealand Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of GLP-2
Table 3. Key Players of Growth Hormone
Table 4. Key Players of Glutamine
Table 5. Key Players of Other
Table 6. Global Drugs for Short Bowel Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Drugs for Short Bowel Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Drugs for Short Bowel Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Drugs for Short Bowel Syndrome Market Share by Regions (2016-2021)
Table 10. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Drugs for Short Bowel Syndrome Market Share by Regions (2022-2027)
Table 12. Drugs for Short Bowel Syndrome Market Trends
Table 13. Drugs for Short Bowel Syndrome Market Drivers
Table 14. Drugs for Short Bowel Syndrome Market Challenges
Table 15. Drugs for Short Bowel Syndrome Market Restraints
Table 16. Global Drugs for Short Bowel Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Drugs for Short Bowel Syndrome Market Share by Players (2016-2021)
Table 18. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Short Bowel Syndrome as of 2020)
Table 19. Ranking of Global Top Drugs for Short Bowel Syndrome Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Drugs for Short Bowel Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Drugs for Short Bowel Syndrome Product Solution and Service
Table 23. Date of Enter into Drugs for Short Bowel Syndrome Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2016-2021)
Table 27. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Drugs for Short Bowel Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2016-2021)
Table 31. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Drugs for Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Drugs for Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Drugs for Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Drugs for Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Drugs for Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Drugs for Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Drugs for Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Drugs for Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Drugs for Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Drugs for Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Drugs for Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Drugs for Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Drugs for Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Drugs for Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Drugs for Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 63. Ardelyx Company Details
Table 64. Ardelyx Business Overview
Table 65. Ardelyx Drugs for Short Bowel Syndrome Product
Table 66. Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 67. Ardelyx Recent Development
Table 68. Emmaus Life Sciences Company Details
Table 69. Emmaus Life Sciences Business Overview
Table 70. Emmaus Life Sciences Drugs for Short Bowel Syndrome Product
Table 71. Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 72. Emmaus Life Sciences Recent Development
Table 73. GLyPharma Therapeutic Company Details
Table 74. GLyPharma Therapeutic Business Overview
Table 75. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product
Table 76. GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 77. GLyPharma Therapeutic Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Drugs for Short Bowel Syndrome Product
Table 81. Merck Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Naia Pharmaceuticals Company Details
Table 84. Naia Pharmaceuticals Business Overview
Table 85. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product
Table 86. Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 87. Naia Pharmaceuticals Recent Development
Table 88. Nutrinia Company Details
Table 89. Nutrinia Business Overview
Table 90. Nutrinia Drugs for Short Bowel Syndrome Product
Table 91. Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 92. Nutrinia Recent Development
Table 93. OxThera Company Details
Table 94. OxThera Business Overview
Table 95. OxThera Drugs for Short Bowel Syndrome Product
Table 96. OxThera Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 97. OxThera Recent Development
Table 98. Sancilio & Company Company Details
Table 99. Sancilio & Company Business Overview
Table 100. Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 101. Sancilio & Company Recent Development
Table 102. Takeda Company Details
Table 103. Takeda Business Overview
Table 104. Takeda Drugs for Short Bowel Syndrome Product
Table 105. Takeda Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 106. Takeda Recent Development
Table 107. Zealand Pharma Company Details
Table 108. Zealand Pharma Business Overview
Table 109. Zealand Pharma Drugs for Short Bowel Syndrome Product
Table 110. Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 111. Zealand Pharma Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Short Bowel Syndrome Market Share by Type: 2020 VS 2027
Figure 2. GLP-2 Features
Figure 3. Growth Hormone Features
Figure 4. Glutamine Features
Figure 5. Other Features
Figure 6. Global Drugs for Short Bowel Syndrome Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Drugs for Short Bowel Syndrome Report Years Considered
Figure 11. Global Drugs for Short Bowel Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Drugs for Short Bowel Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Drugs for Short Bowel Syndrome Market Share by Regions: 2020 VS 2027
Figure 14. Global Drugs for Short Bowel Syndrome Market Share by Regions (2022-2027)
Figure 15. Global Drugs for Short Bowel Syndrome Market Share by Players in 2020
Figure 16. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Short Bowel Syndrome as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Drugs for Short Bowel Syndrome Revenue in 2020
Figure 18. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2016-2021)
Figure 19. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2022-2027)
Figure 20. North America Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Drugs for Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 22. North America Drugs for Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 23. North America Drugs for Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 24. United States Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Drugs for Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 28. Europe Drugs for Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 29. Europe Drugs for Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 30. Germany Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Drugs for Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Drugs for Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Drugs for Short Bowel Syndrome Market Share by Region (2016-2027)
Figure 40. China Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Drugs for Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 48. Latin America Drugs for Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 49. Latin America Drugs for Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 50. Mexico Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Drugs for Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Drugs for Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Drugs for Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 56. Turkey Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Ardelyx Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 60. Emmaus Life Sciences Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 61. GLyPharma Therapeutic Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 63. Naia Pharmaceuticals Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 64. Nutrinia Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 65. OxThera Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 66. Sancilio & Company Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 67. Takeda Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 68. Zealand Pharma Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global Centralized Patient Monitoring System Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 130
    According to this latest study, the 2020 growth of Centralized Patient Monitoring System will have significant change from previous year. By the most conservative estimates of global Centralized Patient Monitoring System market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 490.5 million in 2019. Over the next five years the Centralized Patient Monitoring System market will register a 6.3% CAGR in terms of revenue, the global market size will rea......
  • Global Livestock Animal Vaccines Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 159
    According to this latest study, the 2020 growth of Livestock Animal Vaccines will have significant change from previous year. By the most conservative estimates of global Livestock Animal Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 4632.4 million in 2019. Over the next five years the Livestock Animal Vaccines market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 5868.7 million by 2025.......
  • Global Clinical Reference Laboratory Services Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Clinical Reference Laboratory Services will have significant change from previous year. By the most conservative estimates of global Clinical Reference Laboratory Services market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 11450 million in 2019. Over the next five years the Clinical Reference Laboratory Services market will register a 5.4% CAGR in terms of revenue, the global market size will ......
  • Global Steam Chemical Indicator Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 139
    According to this latest study, the 2020 growth of Steam Chemical Indicator will have significant change from previous year. By the most conservative estimates of global Steam Chemical Indicator market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 105.9 million in 2019. Over the next five years the Steam Chemical Indicator market will register a 6.7% CAGR in terms of revenue, the global market size will reach US$ 137.2 million by 2025. ......
  • Global Oral Guided Bone Regeneration (GTR) Membrane Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 167
    According to this latest study, the 2020 growth of Oral Guided Bone Regeneration (GTR) Membrane will have significant change from previous year. By the most conservative estimates of global Oral Guided Bone Regeneration (GTR) Membrane market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 201.6 million in 2019. Over the next five years the Oral Guided Bone Regeneration (GTR) Membrane market will register a 6.6% CAGR in terms of revenue, the global......
  • Global Non-Wearable Sleep Tracker Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 137
    According to this latest study, the 2020 growth of Non-Wearable Sleep Tracker will have significant change from previous year. By the most conservative estimates of global Non-Wearable Sleep Tracker market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 250.4 million in 2019. Over the next five years the Non-Wearable Sleep Tracker market will register a 13.7% CAGR in terms of revenue, the global market size will reach US$ 418.6 million by 2025.......
  • Global Hematopoietic Stem Cells Transplantation Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 119
    According to this latest study, the 2020 growth of Hematopoietic Stem Cells Transplantation will have significant change from previous year. By the most conservative estimates of global Hematopoietic Stem Cells Transplantation market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2110.6 million in 2019. Over the next five years the Hematopoietic Stem Cells Transplantation market will register a 5.9% CAGR in terms of revenue, the global market siz......
  • Global Non-invasive Glucose Monitoring Device Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Non-invasive Glucose Monitoring Device will have significant change from previous year. By the most conservative estimates of global Non-invasive Glucose Monitoring Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2974.9 million in 2019. Over the next five years the Non-invasive Glucose Monitoring Device market will register a 26.7% CAGR in terms of revenue, the global market size wil......
  • Global Veterinary Rapid Test Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 131
    According to this latest study, the 2020 growth of Veterinary Rapid Test will have significant change from previous year. By the most conservative estimates of global Veterinary Rapid Test market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 493.7 million in 2019. Over the next five years the Veterinary Rapid Test market will register a 8.8% CAGR in terms of revenue, the global market size will reach US$ 692.3 million by 2025. Thi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs